2012
DOI: 10.4321/s1130-01082012001100010
|View full text |Cite
|
Sign up to set email alerts
|

Should the host reaction to anisakiasis influence the treatment?: Different clinical presentations in two cases

Abstract: Gastrointestinal anisakiasis is a parasitic infection occurring in people that consume raw or inadequately cooked fish or squid. It is frequently characterized by severe epigastric pain, nausea and vomiting caused by the penetration of the larvae into the gastric wall. Acute gastric anisakiasis with severe chest discomfort is rarely reported in Italy. On the other hand, gastro-allergic anisakiasis with rash, urticaria and isolated angioedema or anaphylaxis is a clinical entity that has been described only rece… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
8
0
2

Year Published

2014
2014
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 14 publications
0
8
0
2
Order By: Relevance
“…Japan figures at the top of the list for this parasitosis, followed by Spain, due to the high level of fish consumption by inhabitant per year and the wide variety of high-risk preparation methods, although nowadays cases are reported all over the world. Various treatments have been proposed for this illness in cases where symptoms do not require urgent intervention, but in the last two decades clinicians have mainly opted for anthelmintics such as mebendazole, thiabendazole and especially albendazole in an effort to avoid surgery [7][8][9][10][11]. In fact, albendazole is listed as a treatment for anisakiasis on the Centers for Disease Control and Prevention webpage -Anisakiasis (USA) [12], although it points out that it is not FDA approved to treat this illness, as there is no clear evidence of its effectiveness.…”
Section: Introductionmentioning
confidence: 99%
“…Japan figures at the top of the list for this parasitosis, followed by Spain, due to the high level of fish consumption by inhabitant per year and the wide variety of high-risk preparation methods, although nowadays cases are reported all over the world. Various treatments have been proposed for this illness in cases where symptoms do not require urgent intervention, but in the last two decades clinicians have mainly opted for anthelmintics such as mebendazole, thiabendazole and especially albendazole in an effort to avoid surgery [7][8][9][10][11]. In fact, albendazole is listed as a treatment for anisakiasis on the Centers for Disease Control and Prevention webpage -Anisakiasis (USA) [12], although it points out that it is not FDA approved to treat this illness, as there is no clear evidence of its effectiveness.…”
Section: Introductionmentioning
confidence: 99%
“…The present data refers to the possibility of one of the present described 4th stage larvae may be the infective stage of this nematode parasite and its life cycle is a direct one by engulfing larvae-infected fish. Hysterothylacium was described as a zoonotic parasite (Chai et al, 2005, Lopata and Lehrer, 2009, Felizardo et al, 2009 and the first case report of human infection with H. aduncum was reported by Yagi et al, (1996) in a patient complaining of epigastralgia , vomiting, obstruction, diarrhea, ulceration, bleeding and hypersensitivity reactions in the form of urticaria, angioedema, and shock (Pontone et al, 2012) and definite diagnosis can be done only by direct parasite visualization Henriquez-Santana and Villafruela-Cives, 2009).…”
Section: Discussionmentioning
confidence: 99%
“…Various drugs have been used against anisakiasis with no clear results. Single albendazole doses are effective for the treatment of Ascaris lumbricoides, Enterobius vermicularis and Trichuris trichiura, explaining its frequent use to combat human anisakiasis (Moore et al 2002;Pacios et al 2005;Kim et al 2006;Filauro et al 2011;Pontone et al 2012).…”
Section: Discussionmentioning
confidence: 99%